JP2023514242A5 - - Google Patents

Info

Publication number
JP2023514242A5
JP2023514242A5 JP2022548941A JP2022548941A JP2023514242A5 JP 2023514242 A5 JP2023514242 A5 JP 2023514242A5 JP 2022548941 A JP2022548941 A JP 2022548941A JP 2022548941 A JP2022548941 A JP 2022548941A JP 2023514242 A5 JP2023514242 A5 JP 2023514242A5
Authority
JP
Japan
Prior art keywords
sequence
nucleic acid
acid molecule
seq
nucleotides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022548941A
Other languages
English (en)
Japanese (ja)
Other versions
JP7728772B2 (ja
JP2023514242A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/017950 external-priority patent/WO2021163556A1/en
Publication of JP2023514242A publication Critical patent/JP2023514242A/ja
Publication of JP2023514242A5 publication Critical patent/JP2023514242A5/ja
Application granted granted Critical
Publication of JP7728772B2 publication Critical patent/JP7728772B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022548941A 2020-02-12 2021-02-12 遺伝子発現の誘導性選択的スプライシング調節のための組成物および方法 Active JP7728772B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062975400P 2020-02-12 2020-02-12
US62/975,400 2020-02-12
PCT/US2021/017950 WO2021163556A1 (en) 2020-02-12 2021-02-12 Compositions and methods for inducible alternative splicing regulation of gene expression

Publications (3)

Publication Number Publication Date
JP2023514242A JP2023514242A (ja) 2023-04-05
JP2023514242A5 true JP2023514242A5 (cg-RX-API-DMAC7.html) 2024-02-21
JP7728772B2 JP7728772B2 (ja) 2025-08-25

Family

ID=77292961

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022548941A Active JP7728772B2 (ja) 2020-02-12 2021-02-12 遺伝子発現の誘導性選択的スプライシング調節のための組成物および方法

Country Status (9)

Country Link
US (1) US20230340498A1 (cg-RX-API-DMAC7.html)
EP (1) EP4103717A4 (cg-RX-API-DMAC7.html)
JP (1) JP7728772B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220146501A (cg-RX-API-DMAC7.html)
CN (1) CN115605596A (cg-RX-API-DMAC7.html)
AU (1) AU2021218807A1 (cg-RX-API-DMAC7.html)
CA (1) CA3167836A1 (cg-RX-API-DMAC7.html)
IL (1) IL295542A (cg-RX-API-DMAC7.html)
WO (1) WO2021163556A1 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210355509A1 (en) * 2018-08-07 2021-11-18 The Children's Hospital Of Philadelphia Alternative splicing regulation of gene expression and therapeutic methods
CN115023242B (zh) 2019-11-22 2025-03-14 费城儿童医院 腺相关病毒载体变体
WO2023054573A1 (ja) * 2021-09-30 2023-04-06 国立大学法人大阪大学 相同染色体の一方に特異的なdna欠失を有する細胞を製造する方法
US20250346893A1 (en) * 2021-10-22 2025-11-13 Fred Hutchinson Cancer Center Synthetic introns for targeted gene expression
CA3254228A1 (en) 2022-05-18 2023-11-23 The Children's Hospital Of Philadelphia COMPOSITIONS AND METHODS FOR REGULATING INDUCIBLE ALTERNATIVE SPLICING OF GENE EXPRESSION
WO2024060205A1 (zh) * 2022-09-23 2024-03-28 北京基驭医疗科技有限公司 包含基于小分子药物的可变剪接调节元件的核酸分子
WO2024118610A2 (en) * 2022-11-28 2024-06-06 Siren Biotechnology, Inc. Gene therapy vectors for treatment of cancer
WO2024173699A2 (en) * 2023-02-16 2024-08-22 Mammoth Biosciences, Inc. Compositions for the treatment of spinal muscular atrophy
WO2024186892A2 (en) * 2023-03-06 2024-09-12 The Children's Hospital Of Philadelphia Regulated control of rna interference by alternative splicing
EP4701634A1 (en) 2023-04-28 2026-03-04 Kriya Therapeutics, Inc. Riboswitches for regulating gene expression and therapeutic methods of using the same
AU2024286618A1 (en) 2023-06-09 2025-10-30 F. Hoffmann-La Roche Ag Inducible gene expression system
WO2026125303A1 (en) 2024-12-11 2026-06-18 F. Hoffmann-La Roche Ag Inducible gene expression system

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7838657B2 (en) * 2004-12-03 2010-11-23 University Of Massachusetts Spinal muscular atrophy (SMA) treatment via targeting of SMN2 splice site inhibitory sequences
GB2443186A (en) * 2006-10-25 2008-04-30 Oxitec Ltd Expression system for mediating alternative splicing
US8633019B2 (en) * 2008-05-27 2014-01-21 Ptc Therapeutics, Inc. Methods for treating spinal muscular atrophy
EP3406252B1 (en) 2012-02-10 2020-05-13 PTC Therapeutics, Inc. Compounds for treating spinal muscular atrophy
HUE047898T2 (hu) * 2013-10-28 2020-05-28 Invectys Telomerázt kódoló DNS vakcina
CN108603230A (zh) * 2015-10-09 2018-09-28 南安普敦大学 基因表达的调节与蛋白质表达失调的筛选
JP2019535789A (ja) * 2016-11-28 2019-12-12 ピーティーシー セラピューティクス,インコーポレーテッド Rnaスプライシングを調節する方法
US20210355509A1 (en) * 2018-08-07 2021-11-18 The Children's Hospital Of Philadelphia Alternative splicing regulation of gene expression and therapeutic methods
CN114174514A (zh) * 2019-07-25 2022-03-11 诺华股份有限公司 可调节的表达系统
WO2022204471A1 (en) * 2021-03-26 2022-09-29 Ptc Therapeutics Inc. Regulation of transgene expression using a small molecule inducible splicing switch
CN118480543A (zh) * 2024-03-01 2024-08-13 五邑大学 一种可变剪接调节元件及其应用

Similar Documents

Publication Publication Date Title
JP2021532812A5 (cg-RX-API-DMAC7.html)
JP2022508182A5 (cg-RX-API-DMAC7.html)
CN109069672B (zh) 腺相关病毒载体传递微肌营养不良蛋白以治疗肌营养不良症
JP2024009857A5 (cg-RX-API-DMAC7.html)
US10392632B2 (en) AAV8 vector with enhanced functional activity and methods of use thereof
JP2022551986A5 (cg-RX-API-DMAC7.html)
JP2023534999A5 (cg-RX-API-DMAC7.html)
JP2020533959A5 (cg-RX-API-DMAC7.html)
JP7541027B2 (ja) 筋肉発現のためのハイブリッドプロモーター
JP2022547197A5 (cg-RX-API-DMAC7.html)
JP2023537625A5 (cg-RX-API-DMAC7.html)
JP2021534766A5 (cg-RX-API-DMAC7.html)
JP2023500793A5 (cg-RX-API-DMAC7.html)
US20020076754A1 (en) Overcoming AAV vector size limitation through viral DNA hetero-dimerization
JP2017529395A5 (cg-RX-API-DMAC7.html)
JP2022551744A5 (cg-RX-API-DMAC7.html)
JP2023537358A5 (cg-RX-API-DMAC7.html)
US12534741B2 (en) Compositions and methods for treatment of neurological disorders
JP2024530023A5 (cg-RX-API-DMAC7.html)
CN119403823A (zh) 具有增强的肌肉转导效率的肽修饰的aav衣壳
JP2025513066A5 (cg-RX-API-DMAC7.html)
JP2022545378A5 (cg-RX-API-DMAC7.html)
JP2024515626A5 (cg-RX-API-DMAC7.html)
JP2023542131A5 (cg-RX-API-DMAC7.html)
JP2023551254A5 (cg-RX-API-DMAC7.html)